304 related articles for article (PubMed ID: 33198658)
21. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
22. Gastric precancerous lesions among Nigerians with chronic gastritis.
Badmos KB; Ojo OS; Olasode BJ; Arigbabu AO
Niger Postgrad Med J; 2012 Jun; 19(2):92-6. PubMed ID: 22728974
[TBL] [Abstract][Full Text] [Related]
23. Blood type and family cancer history in relation to precancerous gastric lesions.
You WC; Ma JL; Liu W; Gail MH; Chang YS; Zhang L; Hu YR; Fraumeni JF; Xu GW
Int J Epidemiol; 2000 Jun; 29(3):405-7. PubMed ID: 10869310
[TBL] [Abstract][Full Text] [Related]
24. Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk.
Bilgiç F; Gerçeker E; Boyacıoğlu SÖ; Kasap E; Demirci U; Yıldırım H; Baykan AR; Yüceyar H
Turk J Gastroenterol; 2018 Jul; 29(4):427-435. PubMed ID: 30249557
[TBL] [Abstract][Full Text] [Related]
25. Gastric intraepithelial neoplasia in a Western population.
Raftopoulos SC; Kumarasinghe P; de Boer B; Iacobelli J; Kontorinis N; Fermoyle S; Olynyk J; Forrest C; Ee HC; Yusoff IF
Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):48-54. PubMed ID: 22081007
[TBL] [Abstract][Full Text] [Related]
26. Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.
Steenport M; Eom H; Uezu M; Schneller J; Gupta R; Mustafa Y; Villanueva R; Straus EW; Raffaniello RD
Oncol Rep; 2007 Jul; 18(1):235-40. PubMed ID: 17549373
[TBL] [Abstract][Full Text] [Related]
27. How to Manage a Patient With Gastric Intestinal Metaplasia: An International Perspective.
Dinis-Ribeiro M; Kuipers EJ
Gastroenterology; 2020 May; 158(6):1534-1537. PubMed ID: 31926996
[No Abstract] [Full Text] [Related]
28. Intestinal metaplasia surveillance: searching for the road-map.
Zullo A; Hassan C; Repici A; Annibale B
World J Gastroenterol; 2013 Mar; 19(10):1523-6. PubMed ID: 23539645
[TBL] [Abstract][Full Text] [Related]
29. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis.
Akbari M; Tabrizi R; Kardeh S; Lankarani KB
PLoS One; 2019; 14(7):e0219865. PubMed ID: 31348819
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
31. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
33. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study.
González CA; Sanz-Anquela JM; Companioni O; Bonet C; Berdasco M; López C; Mendoza J; Martín-Arranz MD; Rey E; Poves E; Espinosa L; Barrio J; Torres MÁ; Cuatrecasas M; Elizalde I; Bujanda L; Garmendia M; Ferrández Á; Muñoz G; Andreu V; Paules MJ; Lario S; Ramírez MJ; ; Gisbert JP
J Gastroenterol Hepatol; 2016 May; 31(5):953-8. PubMed ID: 26630310
[TBL] [Abstract][Full Text] [Related]
34. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
35. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
Dilaghi E; Baldaro F; Pilozzi E; Conti L; Palumbo A; Esposito G; Annibale B; Lahner E
Am J Gastroenterol; 2021 Sep; 116(9):1859-1867. PubMed ID: 34313623
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions.
Liao X; Lin R; Zhang Z; Tian D; Liu Z; Chen S; Xu G; Su M
J Natl Cancer Inst; 2024 May; 116(5):681-693. PubMed ID: 38258659
[TBL] [Abstract][Full Text] [Related]
37. The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer.
Liu LM; Yan MG; Yang DH; Sun WW; Zhang JX
Eur J Intern Med; 2011 Oct; 22(5):e31-5. PubMed ID: 21925039
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of atrophic gastritis and intestinal metaplasia in first-degree relatives of gastric cancer patients compared with age-sex matched controls.
Oh S; Kim N; Yoon H; Choi YJ; Lee JY; Park KJ; Kim HJ; Kang KK; Oh DH; Seo AY; Lee JW; Shin CM; Park YS; Oh JC; Lee DH; Jung HC
J Cancer Prev; 2013 Jun; 18(2):149-60. PubMed ID: 25337541
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between Helicobacter pylori infection and expression of c-myc, Bcl-2, and Bax protein in different gastric mucosa lesions].
Zhan N; Xiong YY; Lan J; Wang BC; Tian SF; Yu SP
Ai Zheng; 2003 Oct; 22(10):1034-7. PubMed ID: 14558945
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and factors associated with atrophic gastritis and intestinal metaplasia: A multivariate, hospital-based, statistical analysis.
Chitapanarux T; Kongkarnka S; Wannasai K; Sripan P
Cancer Epidemiol; 2023 Feb; 82():102309. PubMed ID: 36470067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
